Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studi...Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studies have found that epigenetics plays an important role in the pathogenesis, prognosis, prevention and treatment of breast cancer Epigenetics is a new direction of research in the field of life sciences. Traditional Chinese medicine, like surgery, radiotherapy, chemotherapy and endocrinotherapy, is an important part of comprehensive treatment of breast cancer.展开更多
Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studi...Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studies have found that epigenetics plays an important role in the pathogenesis, prognosis, prevention and treatment of breast cancer Epigenetics is a new direction of research in the field of life sciences. Traditional Chinese medicine, like surgery, radiotherapy, chemotherapy and endocrinotherapy, is an important part of comprehensive treatment of breast cancer, especially in the consolidation phase of treatment period,which can prevent recurrence or metastasis of breast cancer The theory of epigenetics has some similarities with the theory of TCM, such as ~Correspondence between human being and nature＂, ~Tongbing Yizhi＂ （treating the same disease with different methods）, ~Yibing Tongzhi＂ （treating different diseases with the same method） and the constitution science of TCM. Traditional Chinese medicine can be used to regulate epigenetic modification through DNA methylation, histone modification, miRNA, etc.. The abnormality of epigenetic information can be reversed, which is related to transferring balance between Yin and Yang in the body and making the body restore optimal nature state. This article discusses the application of epigenetics in the study of TCM and in the prevention and treatment of breast cancer. It is a multidisciplinary review to explore the basis about epigenetics in prevention and treatment of breast cancer with TCM, and provide a reference for clinical practice展开更多
OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorec...OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorectal cancer prevention and treatment in the clinic and to find novel directions for new drug discovery for colorectal cancer.METHODS: We used Pub Med and Google to search for and collect scientific publications for a full evaluation of current evidence in the literature indicating the potential role of Chinese herbal medicines and their respective ingredients as effective candidatesforcolorectalcancerpreventionandtreatment.RESULTS: We extracted a detailed description of potential therapeutic Chinese herbal medicines and their constituent ingredients that target different mechanisms in colorectal cancer such as gene mutation, dysregulation of signaling pathways, metabolism disorders, and the inflammatory microenvironment, including both conventional and non-conventional approaches.CONCLUSION: TCM may be a promising complementary and alternative therapy for the treatment of colorectal cancer.展开更多
OBJECTIVE: To compare the effects of integrated Chinese-Western therapy versus Western therapy alone on the survival rate of patients with non-small-cell lung cancer (NSCLC) at middle-late stage and to evaluate progno...OBJECTIVE: To compare the effects of integrated Chinese-Western therapy versus Western therapy alone on the survival rate of patients with non-small-cell lung cancer (NSCLC) at middle-late stage and to evaluate prognostic factors. METHODS: We selected 98 inpatients with middle-late stage NSCLC diagnosed from March 2009 to March 2011 and randomly divided them into two groups, with 49 cases in each group, and the clinical data were analyzed retrospectively.The control group was treated by the combined methods of Western Medicine, including chemotherapy, supportive treatment and symptomatic treatment. The observation group was treated by injection and prescriptions of Chinese medicine based on Traditional Chinese Medicine syndrome differentiation and by the same combined methods of western treatment used in the control group. After treatment, the survival rates of the patients were compared by the stage of cancer and evaluation of 24 prognostic factors analyzed by a Cox regressionmodel, and the clinical data were statistically analyzed. RESULTS: The survival rates of all patients were over 90.0% at 1 and 3 months after treatment with no significant differences between the two groups (P>0.05); In the observation group the survival rates at 6 months and 1 year were 93.4% and 42.8%, respectively, being superior to 85.6% and 18.3% in the control group (P<0.05). The median survival time in the observation group was superior to the control group (P<0.05); The effects of 24 prognostic factors were significantly better in the observation group than in the control group (P<0.05). CONCLUSION: Integrated Chinese-western therapy can significantly improve the survival rate in patients with middle-late stage NSCLC and improve prognostic factors compared with western therapy alone.展开更多
文摘Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studies have found that epigenetics plays an important role in the pathogenesis, prognosis, prevention and treatment of breast cancer Epigenetics is a new direction of research in the field of life sciences. Traditional Chinese medicine, like surgery, radiotherapy, chemotherapy and endocrinotherapy, is an important part of comprehensive treatment of breast cancer.
文摘Breast cancer has been an important factor that influenced women＇s health with its increasing incidence. The conventional research suggests that breast cancer is caused by genetic mutations, while some advanced studies have found that epigenetics plays an important role in the pathogenesis, prognosis, prevention and treatment of breast cancer Epigenetics is a new direction of research in the field of life sciences. Traditional Chinese medicine, like surgery, radiotherapy, chemotherapy and endocrinotherapy, is an important part of comprehensive treatment of breast cancer, especially in the consolidation phase of treatment period,which can prevent recurrence or metastasis of breast cancer The theory of epigenetics has some similarities with the theory of TCM, such as ~Correspondence between human being and nature＂, ~Tongbing Yizhi＂ （treating the same disease with different methods）, ~Yibing Tongzhi＂ （treating different diseases with the same method） and the constitution science of TCM. Traditional Chinese medicine can be used to regulate epigenetic modification through DNA methylation, histone modification, miRNA, etc.. The abnormality of epigenetic information can be reversed, which is related to transferring balance between Yin and Yang in the body and making the body restore optimal nature state. This article discusses the application of epigenetics in the study of TCM and in the prevention and treatment of breast cancer. It is a multidisciplinary review to explore the basis about epigenetics in prevention and treatment of breast cancer with TCM, and provide a reference for clinical practice
基金Supported by National Natural Science Foundation of China(Research for the Mechanism of Fei-Liu-Ping Ointment Regulating Tumor Inflammatory Microenvironment to Prevent Lung Cancer Metastasis,No.81273718)China Postdoctoral Science Foundation(In vitro study on Fei-Liu-Ping ointment preventing lung cancer metastasis caused by inflammatory microenvironment,No.2012T50199)
文摘OBJECTIVE: To explore the role of Traditional Chinese Medicine(TCM) in the prevention and treatment of colorectal cancer and identify possible therapeutic targets of TCM to provide clues for the use of TCM for colorectal cancer prevention and treatment in the clinic and to find novel directions for new drug discovery for colorectal cancer.METHODS: We used Pub Med and Google to search for and collect scientific publications for a full evaluation of current evidence in the literature indicating the potential role of Chinese herbal medicines and their respective ingredients as effective candidatesforcolorectalcancerpreventionandtreatment.RESULTS: We extracted a detailed description of potential therapeutic Chinese herbal medicines and their constituent ingredients that target different mechanisms in colorectal cancer such as gene mutation, dysregulation of signaling pathways, metabolism disorders, and the inflammatory microenvironment, including both conventional and non-conventional approaches.CONCLUSION: TCM may be a promising complementary and alternative therapy for the treatment of colorectal cancer.
文摘OBJECTIVE: To compare the effects of integrated Chinese-Western therapy versus Western therapy alone on the survival rate of patients with non-small-cell lung cancer (NSCLC) at middle-late stage and to evaluate prognostic factors. METHODS: We selected 98 inpatients with middle-late stage NSCLC diagnosed from March 2009 to March 2011 and randomly divided them into two groups, with 49 cases in each group, and the clinical data were analyzed retrospectively.The control group was treated by the combined methods of Western Medicine, including chemotherapy, supportive treatment and symptomatic treatment. The observation group was treated by injection and prescriptions of Chinese medicine based on Traditional Chinese Medicine syndrome differentiation and by the same combined methods of western treatment used in the control group. After treatment, the survival rates of the patients were compared by the stage of cancer and evaluation of 24 prognostic factors analyzed by a Cox regressionmodel, and the clinical data were statistically analyzed. RESULTS: The survival rates of all patients were over 90.0% at 1 and 3 months after treatment with no significant differences between the two groups (P>0.05); In the observation group the survival rates at 6 months and 1 year were 93.4% and 42.8%, respectively, being superior to 85.6% and 18.3% in the control group (P<0.05). The median survival time in the observation group was superior to the control group (P<0.05); The effects of 24 prognostic factors were significantly better in the observation group than in the control group (P<0.05). CONCLUSION: Integrated Chinese-western therapy can significantly improve the survival rate in patients with middle-late stage NSCLC and improve prognostic factors compared with western therapy alone.
